-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Nxtx2dY/bTqR7sqZMdmLEHynkck5IpqKWKd41WuskZc1kcxLCJYJujcoRn2IR7Be oGsD+dA8rXNbFhhCDDHDZQ== 0001127602-10-008370.txt : 20100311 0001127602-10-008370.hdr.sgml : 20100311 20100311175157 ACCESSION NUMBER: 0001127602-10-008370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100309 FILED AS OF DATE: 20100311 DATE AS OF CHANGE: 20100311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAGEMANN ROBERT CENTRAL INDEX KEY: 0001222676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 10675181 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-03-09 0001022079 QUEST DIAGNOSTICS INC DGX 0001222676 HAGEMANN ROBERT C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & Chief Financial Officer Common Stock 2010-03-09 4 A 0 25161 0 A 126530 D Common Stock 2010-03-09 4 F 0 11663 55.765 D 114867 D Common Stock 1745 I SDCP Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 12, 2007, approved in accordance with the requirements of Rule 16b-3(d). Disposition of common stock to the issuer solely to cover the tax withholding obligations arising from the settlement of said performance share award. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Robert Hagemann 2010-03-11 -----END PRIVACY-ENHANCED MESSAGE-----